IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents

AM Liberatore, H Coulomb, D Pons, O Dutruel… - Molecular cancer …, 2008 - AACR
Tubulin is a validated target for antitumor drugs. However, the effectiveness of these
microtubule-interacting agents is limited by the fact that they are substrates for drug efflux …

In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient …

H Fridborg, P Nygren, S Dhar, K Csoka… - Journal of …, 1996 - europepmc.org
The feasibility of combined studies on a cell-line panel and primary cultures of patient tumor
cells in the preclinical evaluation of new anticancer drugs was evaluated in a study of the …

Markedly diminished drug resistance-inducing properties of vinflunine (20′, 20′-difluoro-3′, 4′-dihydrovinorelbine) relative to vinorelbine, identified in murine and …

C Etiévant, A Kruczynski, JM Barret, AS Tait… - Cancer chemotherapy …, 2001 - Springer
Purpose: Vinflunine (VFL) is a novel Vinca alkaloid with markedly superior experimental in
vivo antitumour activity to its parent molecule, vinorelbine (Navelbine, NVB), against a panel …

Long‐lasting accumulation of vinblastine in inostamycin‐treated multidrug‐resistant KB cells

M Kawada, K Umezawa - Japanese journal of cancer research, 1991 - Wiley Online Library
Inostamycin, a novel polyether compound, reverses multidrug resistance in KB cells. The
mechanism of its action was studied by use of radioactively labeled vinblastine. Inostamycin …

Phase I and pharmacokinetic study of rhizoxin

D Bissett, MA Graham, A Setanoians, GA Chadwick… - Cancer research, 1992 - AACR
Rhizoxin is a tubulin-binding cytotoxic compound, isolated from the fungus Rhizopus
chinensis, with significant antineoplastic activity in several murine and human tumor models …

[PDF][PDF] Vincristine as an inductor of drug resistance marker expression in neoplastic cells

A Breier, D Imrichova, H Paulikova… - … and Impacts on …, 2013 - researchgate.net
Vincristine is known as an effective agent for chemotherapy of neoplastic diseases. Its main
pharmacological activity is known to be linked to its inhibition of microtubule dynamics …

Tumor Selective Effect of RS-1541 (Palmitoyl-Rhizoxin) in M5076 Sarcoma and Host Tissues in Vivo

T Tokui, N Maeda, C Kuroiwa, K Sasagawa… - Pharmaceutical …, 1995 - Springer
Abstract RS-1541 is a 13-O-palmitoyl derivative of rhizoxin, an inhibitor of tubulin
polymerization. After intravenous administration of RS-1541 to mice bearing M5076 …

The dithiane Ro 44-5912 enhances vinblastine sensitivity of drug resistant and parental KB lines in vivo

JF Eliason, R Sawada, T Tsukaguchi… - European Journal of …, 1995 - Elsevier
The multidrug resistance modifying activity of a dithiane analogue of tiapamil, Ro 44-5912,
was examined in vivo. Results of acute toxicity studies in mice indicated that lethal toxicity …

Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells

K Nishio, T Nakamura, Y Koh… - … Journal of the …, 2001 - Wiley Online Library
Abstract BACKGROUND Oncoprotein 18 (op18) was first isolated as a molecule
overexpressed in several malignant cells, suggesting a function of op18 in malignant …

Vinflunine (20′, 20′-difluoro-3′, 4′-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo …

C Etievant, JM Barret, A Kruczynski, D Perrin… - Investigational new …, 1998 - Springer
Vinflunine (VFL) is a novel derivative of vinorelbine (NVB, Navelbine®), which has shown
markedly superior antitumor activity to NVB, in various experimental animal models. To …